Market Tracker

09/27 5:16pm ET

Perrigo Company PLC (NYSE:PRGO)

96.77
Delayed Data
As of 4:02pm ET
 +1.04 / +1.09%
Today’s Change
82.50
Today|||52-Week Range
167.92
-33.12%
Year-to-Date
Inside the Recent Surge in Biotech ETFs
Sep 14 / Zacks.com - Paid Partner Content
Perrigo shares jump as activist Starboard's stake revealed
Sep 12 / FT.com - Paid Partner Content

Today’s Trading

Previous close95.73
Today’s open95.34
Day’s range94.85 - 97.20
Volume2,005,101
Average volume (3 months)2,281,275
Market cap$13.7B
Dividend yield0.60%
Data as of 4:02pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+36.36%
P/E ratio20.4
Price/Sales3.82
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+0.02+0.02%
BMRNBiomarin Pharmaceuti...+1.18+1.23%
INCYIncyte Corp+0.31+0.35%
VRXValeant Pharmaceutic...+0.39+1.51%
Data as of 4:14pm ET, 09/27/2016

Financials

Next reporting dateOctober 20, 2016
EPS forecast (this quarter)$1.59
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts